Injection of contrast material into a sinus tract for diagnostic sinography (X-ray visualization of the tract's extent and communication).
Verified May 8, 2026 · 5 sources ↓
- Medicare
- $135.61
- Total RVUs
- 4.06
- Global, days
- 0
- Region
- Other
Documentation requirements
What must appear in the operative or office note to support the claim.
Source · Editorial brief grounded in 5 cited references ↓
- Identify the anatomic location and clinical indication for the sinus tract (e.g., chronic osteomyelitis, post-surgical wound, foreign body reaction)
- Document the volume and type of contrast agent injected into the tract
- Record the extent of tract visualization and any communications with bone, joint, or adjacent structures noted on sinography
- Specify who performed the injection versus who interpreted the imaging, to support separate billing of the technical and professional components when applicable
- Include pre-procedure assessment confirming the tract is patent and the clinical reason fluoroscopic or plain-film sinography was medically necessary
Applicable modifiers
Modifiers commonly billed with this code.
Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual
What this code covers
Source · Editorial summary grounded in 5 cited references ↓
CPT 20501 covers the injection of contrast medium into a musculoskeletal sinus tract — a pathological channel extending from a deep infection, foreign body, or osteomyelitis to the skin surface — for the purpose of radiographic mapping. The contrast outlines the tract's depth, direction, and any bony or soft-tissue communication that clinical exam alone cannot reveal. The global period is 000, meaning routine pre- and post-service work on the same day is bundled but there is no postoperative period extending beyond that day.
The imaging interpretation is not included in 20501. If the radiologist or treating physician reads the sinogram separately, that interpretation requires a distinct radiology code billed with modifier 26. The injection and the read are separable services — don't collapse them into a single line without confirming who performed each component. Podiatry accounts for a disproportionate share of 20501 utilization, reflecting its common use in chronic diabetic foot wounds and postoperative soft-tissue infections of the foot.
RVU & reimbursement
Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.
Source · CMS Physician Fee Schedule, RVU26A · January 2026
| Work RVU | 0.74 |
| Practice expense RVU | 3.25 |
| Malpractice RVU | 0.07 |
| Total RVU | 4.06 |
| Medicare national rate | $135.61 |
| Global period | 0 days |
Payment by site of service
Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.
Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026
| Setting | Medicare rate (national) |
|---|---|
Office (PFS non-facility) Procedure performed in physician's office | $135.61 |
Common denial reasons
The recurring reasons claims for CPT 20501 get rejected.
Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓
- Missing distinct imaging interpretation documentation when modifier 26 is appended for the professional component read
- Bundling conflict when fluoroscopy or other radiologic guidance is billed separately without documentation that it represents a distinct service beyond the sinogram itself
- Medical necessity denial when the note lacks a clear diagnosis linking the sinus tract to an underlying pathology (e.g., osteomyelitis ICD-10, retained foreign body)
- Same-day E&M billed without modifier 25 when the decision to perform the sinography and the E&M are indistinguishable in the documentation
Frequently asked questions
Source · Generated from the editorial pipeline, verified against 5 cited references ↓
01Does 20501 include the radiologic interpretation?
02Can I bill a same-day E&M with 20501?
03What ICD-10 codes typically support 20501?
04Can 20501 be billed bilaterally?
05Is fluoroscopy guidance separately billable with 20501?
06What is the global period for 20501?
Sources & references
Editorial content was developed using the following public sources. Last verified May 8, 2026.
- 01CMS Physician Fee Schedule 2026
- 02cms.govhttps://www.cms.gov/files/document/2025nccimedicarepolicymanualcompletepdf.pdf
- 03cms.govhttps://www.cms.gov/files/document/2026-medicaid-ncci-chapter-12-policy-manual.pdf
- 04cms.govhttps://www.cms.gov/files/document/2026-medicaid-ncci-chapter-1-policy-manual.pdf
- 05cgsmedicare.comhttps://www.cgsmedicare.com/medicare_dynamic/j15/partb/ptpb/ptp.aspx
Mira AI Scribe
Mira's AI scribe captures the tract's anatomic site, the contrast agent used, injection technique, and the radiographic findings (depth, direction, bony communication) directly from the physician's dictation. That detail satisfies the medical necessity and documentation requirements that most trigger a sinography denial — auditors specifically look for the absence of tract characterization in the procedure note.
See how Mira captures CPT 20501 documentation